✦ LIBER ✦

Cardiovascular risk and antihypertensive treatment in French elderly hypertensives: Lessons from the SHEAF study

✍ Scribed by J.M. Mallion; N. Genès; L. Vaur; G. Chatellier; B. Vaı̈sse; P. Clerson; G. Bobrie

Book ID: 117599443
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 183 KB
Volume: 13
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(00)00984-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blood pressure levels, risk factors and

Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study

✍ Mallion, J M; Genès, N; Vaur, L; Clerson, P; Vaïsse, B; Bobrie, G; Chatellier, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Quality of Life During Antihypertensive

Quality of Life During Antihypertensive Treatment: Lessons From the Systolic Hypertension in the Elderly Program

✍ William B Applegate 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Antihypertensive treatment in elderly hy

Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders

✍ D. I. Hadjiev; P. P. Mineva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Incidence and Predictors of Angioedema i

Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

✍ Linda B. Piller; Charles E. Ford; Barry R. Davis; Chuke Nwachuku; Henry R. Black 📂 Article 📅 2006 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 229 KB

Key learnings from the STOP-Hypertension

Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly

✍ Lennart Hansson; Björn Dahlöf; Tord Ekbom; Lars Lindholm; Bengt Scherstén; Per-O 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 288 KB

The Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) is an ongoing multicenter, randomized, double-blind study of antihypertensive treatment (beta-blockers or diuretics) compared to placebo in hypertensive men and women aged 70-84 years. The main trial, which is now in progress,

Absence of an interaction between the AC

Absence of an interaction between the ACE insertion-deletion polymorphism and ACE inhibitor versus other antihypertensive treatments on cardiovascular risk in high-risk hypertensives: The Genhat study

✍ Donna Arnett; Barry Davis; Charles Ford; Eric Boerwinkle; Cathie Leiendecker-Fos 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB